Rocket Medical Devices Inc. is presently enjoying relatively
high growth because of a surge in the demand for its new product.
Management expects earnings and dividends to grow at a rate of 20%
for the next 3 years, after which competition will probably reduce
the growth rate in earnings and dividends to 15% for the next two
years, and then to a long-term growth of 3% forever. The company’s
last dividend, D0, was $0.80, its beta is 1.20, the market risk
premium is 5.50%, and the risk-free rate is 2.00%.
What is the current fair market price of the common stock?
Calculate!
Formulae
Get Answers For Free
Most questions answered within 1 hours.